Hematology & Oncology Doctors in Greenbelt, MD Accepting Medicare

4 Hematology & Oncology doctors found. Showing 1 - 4

Dr. Sajeev Anand, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7501 Greenway Center Dr Ste 500, Greenbelt, MD 20770 Phone: 301-373-7900    Fax: 301-373-6900

Dr. Ari D. Fishman, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7525 Greenway Center Dr, Suite 205, Greenbelt, MD 20770 Phone: 301-982-9800    Fax: 301-982-2420

Dr. Martin D Weltz, D.O. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7525 Greenway Center Dr, Ste 205, Greenbelt, MD 20770 Phone: 301-982-9800    Fax: 301-982-2420

Mr. Thomas A Bensinger, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 7525 Greenway Center Dr, Ste 205, Greenbelt, MD 20770 Phone: 301-982-9800    Fax: 301-982-2420

News Archive

Psychiatric health association applauds signing of The Patient Protection and Affordable Care Act

Today President Barack Obama signed into law The Patient Protection and Affordable Care Act (H.R.3590). As an association representing behavioral healthcare professionals and organizations, we are committed to improving the lives of people of all ages experiencing psychiatric and substance use disorders. This historic legislation offers hope and help in a number of ways.

Sorin launches FDA-approved PARADYM RF family of ICDs and CRT-D devices

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced today at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, FDA approval and commercial launch of the PARADYM RF family of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT-D) devices.

WVU researchers investigate the best 'dose' of telehealth for patients with chronic conditions

More than ever, patients are using telehealth to ask doctors and nurses about worrying blood-pressure readings, nauseating migraines and stubborn foot ulcers. But for patients with chronic conditions, how frequent should telehealth appointments be? Can that frequency change? Under what conditions?

Researchers deploy new tool in study of tubulin tyrosine ligase in tumor growth

Many of the newest weapons in the war on cancer come in the form of personalized therapies that can target specific changes in an individual's tumor. By disrupting molecular processes in tumor cells, these drugs can keep the tumor from growing and spreading. At the forefront of this work are Binghamton University researchers, Susan Bane, and Susannah Gal, who are deploying a new tool in their study of an enzyme called tubulin tyrosine ligase, or TTL.

NCI launches new drug formulary to help expedite use of agents in clinical studies

The National Cancer Institute today launched a new drug formulary (the "NCI Formulary") that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical studies and cancer clinical trials.

Read more Medical News

› Verified 9 days ago